[
  {
    "criterion": "Provides accurate information about sotalol's elimination by the kidneys and its impact on eGFR",
    "axis": "accuracy",
    "point": 5
  },
  {
    "criterion": "Fails to mention the importance of monitoring the QT interval in patients with reduced renal function",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Does not consider alternative dosing intervals based on the patient's eGFR",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Incorrectly assumes that sotalol's elimination is primarily hepatic",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Provides a clear and concise explanation of the importance of adjusting dosing intervals based on eGFR",
    "axis": "communication_quality",
    "point": 7
  },
  {
    "criterion": "Does not address the potential risks of prolonging QT interval in patients with reduced renal function",
    "axis": "context_awareness",
    "point": -2
  },
  {
    "criterion": "Provides a logical and well-reasoned explanation of the need to lengthen dosing intervals as eGFR drops",
    "axis": "context_awareness",
    "point": 6
  },
  {
    "criterion": "Fails to provide any information about the potential impact of sotalol on the patient's eGFR",
    "axis": "completeness",
    "point": -9
  },
  {
    "criterion": "Provides accurate information about the importance of monitoring the patient's eGFR and adjusting dosing intervals accordingly",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Does not consider alternative medications that may be more suitable for patients with reduced renal function",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Provides a clear and concise explanation of the potential risks and benefits of adjusting dosing intervals based on eGFR",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Incorrectly assumes that sotalol's elimination is primarily renal",
    "axis": "accuracy",
    "point": -7
  },
  {
    "criterion": "Provides accurate information about the potential risks of prolonged QT interval in patients with reduced renal function",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Does not address the potential impact of sotalol on the patient's overall health",
    "axis": "context_awareness",
    "point": -1
  },
  {
    "criterion": "Provides a logical and well-reasoned explanation of the importance of adjusting dosing intervals based on eGFR",
    "axis": "context_awareness",
    "point": 8
  },
  {
    "criterion": "Fails to provide any information about the potential benefits of adjusting dosing intervals based on eGFR",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Provides accurate information about the importance of monitoring the patient's eGFR and adjusting dosing intervals accordingly",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Does not consider alternative dosing intervals based on the patient's overall health",
    "axis": "completeness",
    "point": -2
  }
]